1. "2013"
  2. "Miguel-Angel Perales"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (9)
  3. Book Section (1)
Groups
  1. Bone Marrow Transplant (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Biostatistics Service (15)
  6. Epidemiology and Biostatistics (15)

More Groups

People
  1. Miguel-Angel Perales (25)
  2. Jenna Goldberg (16)
  3. Sergio Giralt (14)
  4. Hugo Castro-Malaspina (12)
  5. Juliet Barker (12)
  6. Sean Devlin (12)

More People

Years
  1. 2013 (25)
Publications
  1. Blood (10)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Bone Marrow Transplantation (2)
  4. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (1)
  5. Journal of Cellular and Molecular Medicine (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Elsevier Inc. (9)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (1)
  5. Public Library of Science (1)
  6. Wiley-Blackwell Publishing Ltd. (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation is effective in patients with advanced systemic mastocytosis: A multicenter retrospective analysis
    Meeting Abstract

    Ustun, C.; Reiter, A.; Scott, B. L.; Nakamura, R.; Gandhi, D.; Kreil, S.; Shanley, R.; Hogan, W. J.; Perales, M. A.; Shore, T. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Low CD34 cell dose is associated with higher non-relapse and overall mortality after reduced intensity conditioning hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndrome
    Meeting Abstract

    Thörlén, J.; Ringdén, O.; Le Rademacher, J.; Battiwalla, M.; Chen, J.; Ho, V. T.; Kebriaei, P.; Keever-Taylor, C. A.; Kindwall-Keller, T. L.; Lazarus, H. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The hematopoietic cell transplant-co-morbidity index (HCT-CI) predicts outcomes after T cell depleted (TCD) allogeneic HCT for AML and MDS
    Meeting Abstract

    Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S. M.; Malloy, M. A.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Outcomes in patients with acute lymphoblastic leukemia in first or second complete remission receiving ex-vivo T-cell depleted or unmodified allografts: Comparison of results at two institutions
    Meeting Abstract

    Hobbs, G. S.; Hilden, P.; Hamdi, A.; Goldberg, J. D.; Poon, M.; Ledesma, C.; Devlin, S.; Rondon, G.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Transplantation of peripheral blood progenitor cells (PBPC) as compared to bone marrow (BM) from unrelated related donors for hematologic cancers using fludarabine-alkylating agent based reduced intensity conditioning regimens
    Meeting Abstract

    Eapen, M.; Logan, B. R.; Horowitz, M. M.; Zhong, X.; Perales, M. A.; Lee, S. J.; Rocha, V.; Soiffer, R. J.; Weisdorf, D. J.; Champlin, R. E.
    Blood (2013)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)
    Meeting Abstract

    Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cell-selected PBSC results in 100% CB engraftment with enhanced myeloid recovery
    Meeting Abstract

    Barker, J. N.; Ponce, D. M.; Dahi, P. B.; Devlin, S.; Evans, K. L.; Lubin, M. N.; Meagher, R.; Reich, L.; Castro-Malaspina, H.; Goldberg, J. D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Enhanced responses to tumor immunization following total body irradiation are time-dependent
    Journal Article

    Diab, A.; Jenq, R. R.; Rizzuto, G. A.; Cohen, A. D.; Huggins, D. W.; Merghoub, T.; Engelhorn, M. E.; Guevara-Patiño, J. A.; Suh, D.; Hubbard-Lucey, V. M.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save